Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 672323-32-9 | MDL No. : | MFCD09953598 |
Formula : | C6H5N3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WLKWWISJQDPNNJ-UHFFFAOYSA-N |
M.W : | 151.12 | Pubchem ID : | 135787026 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 39.04 |
TPSA : | 63.99 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.56 cm/s |
Log Po/w (iLOGP) : | 0.47 |
Log Po/w (XLOGP3) : | -0.47 |
Log Po/w (WLOGP) : | -0.71 |
Log Po/w (MLOGP) : | -0.13 |
Log Po/w (SILICOS-IT) : | -0.14 |
Consensus Log Po/w : | -0.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.82 |
Solubility : | 23.0 mg/ml ; 0.152 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.41 |
Solubility : | 59.2 mg/ml ; 0.391 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.05 |
Solubility : | 13.4 mg/ml ; 0.0889 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.96 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 679394-11-7 ]
N-(4-Bromo-1-methyl-1H-pyrazol-5-yl)pivalamide
Similarity: 0.70
[ 138904-35-5 ]
7-Amino-4,5-dihydro-5-oxo-pyrazolo[1,5-a]pyrimidine-3-carbonitrile
Similarity: 0.64
[ 18213-75-7 ]
5-Amino-1-methyl-1H-pyrazole-4-carboxamide
Similarity: 0.61
[ 1628208-23-0 ]
6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile
Similarity: 0.61
[ 57489-70-0 ]
7-Hydroxypyrazolo[1,5-a]pyrimidin-5(4H)-one
Similarity: 0.60
[ 126352-69-0 ]
4,5,6,7-Tetrahydropyrazolo[1,5-a]pyrimidine
Similarity: 0.76
[ 1260879-61-5 ]
7-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine
Similarity: 0.71
[ 138904-35-5 ]
7-Amino-4,5-dihydro-5-oxo-pyrazolo[1,5-a]pyrimidine-3-carbonitrile
Similarity: 0.64
[ 1628208-23-0 ]
6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile
Similarity: 0.61
[ 57489-70-0 ]
7-Hydroxypyrazolo[1,5-a]pyrimidin-5(4H)-one
Similarity: 0.60